ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
3 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
10 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
10
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
8 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
8 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
1 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BITOC
|
|
mxdbg
|
68 |
21K |
4 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
68
|
21K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
3 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
3 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
7 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
mxdbg
|
381 |
116K |
6 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
381
|
116K
|
6
|
|
Humour
|
|
Re:
Haggis.....
|
|
mxdbg
|
3 |
1.1K |
2 |
29/09/23 |
29/09/23 |
Humour
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Full Year Statutory Accounts and Appendix 4E
|
|
mxdbg
|
184 |
47K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
184
|
47K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
mxdbg
|
124 |
43K |
13 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
124
|
43K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
mxdbg
|
124 |
43K |
3 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
43K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
mxdbg
|
124 |
43K |
1 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
43K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
mxdbg
|
124 |
43K |
13 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
43K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
mxdbg
|
124 |
43K |
9 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
124
|
43K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mxdbg
|
69 |
22K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
69
|
22K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
mxdbg
|
5.0K |
1.4M |
5 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Bat Phone
|
|
mxdbg
|
3 |
1.9K |
3 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
3
|
1.9K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
6 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Billion-Dollar Deal known as xDeal
|
|
mxdbg
|
21 |
9.1K |
5 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
21
|
9.1K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
0 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
358
|
109K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
2 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
358
|
109K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
4 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
358
|
109K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
6 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
358
|
109K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
3 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
358
|
109K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
COVID19 - competitive landscape
|
|
mxdbg
|
358 |
109K |
4 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
358
|
109K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Commencement Phase 2 Covid-19 Clinical Trial
|
|
mxdbg
|
102 |
27K |
4 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
102
|
27K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
4 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Myeloid Cells
|
|
mxdbg
|
38 |
9.3K |
3 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
38
|
9.3K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Myeloid Cells
|
|
mxdbg
|
38 |
9.3K |
0 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
38
|
9.3K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Myeloid Cells
|
|
mxdbg
|
38 |
9.3K |
8 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
38
|
9.3K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
0 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
3 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
11 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
13K
|
6.3M
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: International Presentation of BIT225 COVID-19 Data
|
|
mxdbg
|
182 |
51K |
1 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
182
|
51K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Can Big Pharma be trusted with the cure for Covid and HIV?
|
|
mxdbg
|
61 |
16K |
1 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
61
|
16K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Can Big Pharma be trusted with the cure for Covid and HIV?
|
|
mxdbg
|
61 |
16K |
1 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
61
|
16K
|
1
|
|
Humour
|
|
Re:
Australia Day v Invasión Day
|
|
mxdbg
|
104 |
38K |
4 |
25/01/23 |
25/01/23 |
Humour
|
104
|
38K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BITOA & BITOB oppies at it like BIT225
|
|
mxdbg
|
174 |
72K |
2 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
174
|
72K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BITOA & BITOB oppies at it like BIT225
|
|
mxdbg
|
174 |
72K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
174
|
72K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BITOA & BITOB oppies at it like BIT225
|
|
mxdbg
|
174 |
72K |
2 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
174
|
72K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BITOA & BITOB oppies at it like BIT225
|
|
mxdbg
|
174 |
72K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
174
|
72K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BITOA & BITOB oppies at it like BIT225
|
|
mxdbg
|
174 |
72K |
0 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
174
|
72K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
6 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
6
|
|